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Experiments were conducted to evaluate the effects of amphetamine (0.4 mg/kg of body weight/day) on the 
development of oral candidiasis in Sprague-Dawley rats. Animals were submitted to surgical hyposalivation in 
order to facilitate the establishment and persistence of Candida albicans infection. Treatment with drugs 
(placebo or amphetamine) was initiated 7 days before C. albicans inoculation and lasted until the end of the 
experiments, day 15 postinoculation. Establishment of C. albicans infection was evaluated by swabbing the 
inoculated oral cavity with a sterile cotton applicator on days 2 and 15 after inoculation, followed by plating on 
YEPD (yeast extract-peptone-dextrose) agar. Tissue injury was determined by the quantification of the 
number and type (normal or abnormal) of papillae on the dorsal tongue per microscopic field. A 
semiquantitative scale was devised to assess the degree of colonization of the epithelium by fungal hyphae. Our 
results show that amphetamine exacerbates C. albicans infection of the tongues of rats. Significant increases in 
Candida counts, the percentage of the tongue’s surface covered with clinical lesions, the percentage of 
abnormal papillae, and the colonization of the epithelium by fungal hyphae were found in amphetamine-
treated rats compared to those found in the rats injected with a placebo. The last two parameters increased in 
rats treated with the placebo compared to the parameters of the untreated control rats. 
Candida albicans is a major cause of oral and esophageal infections in immunocompromised patients 
(21). This opportunistic human pathogen preferentially causes invasive and disseminated infections in 
patients with defective phagocytic defenses and serious mucocutaneous infection in patients with 
deficiencies in T-cell function. Phagocytes appear to protect the host from fungal colonization even in the 
absence of adaptive immune mechanisms, while as-yet-undefined T-cell-dependent factors seem 
necessary for the control of C. albicans on body surfaces (21). 
In our previous research we had observed adverse effects of amphetamine on the immune systems of 
rodents that may lead to more severe C. albicans infections. Both defective T-cell-mediated immunity 
and qualitative or quantitative defects of phagocytes have been found in mice repeatedly injected with 
amphetamine (0.4 mg/kg of body weight/day). They showed a reduction in thymus and spleen 
cellularities, the peripheral T-lymphocyte population, the blastogenic response of T- and B-lymphocyte 
mitogenic functions (11, 25), the natural killer (NK) cell activity, and the capacity of T cells to generate 
cytotoxic T lymphocytes in mixed lymphocyte cultures and in vivo (23). A decrease in in vitro and in 
vivo phagocytoses (12), measured by the zymosan particle uptake method and the carbon clearance test, 
respectively, and a delayed-type hypersensitivity response in mice (13) were also observed. These adverse 
effects of amphetamine appeared after 4 days of administration and lasted until the end of the experiments 
(day 20), with a maximum intensity at 8 to 12 days of administration. Nevertheless, there is little data on 
the effects of this compound on the development of C. albicans infection. This is important since drug 
addiction is commonly associated with candidiasis, especially in human immunodeficiency virus patients, 
and since the potential immunosuppressive properties of drugs like amphetamine are not always taken 
into account in the pathogenicity of C. albicans. To further elucidate this relationship, we studied the 
effects of repeated injections of amphetamine on the development of oral candidiasis in rats.  
MATERIALS AND METHODS 
Animals. Two-month-old male pathogen-free rats of the Sprague-Dawley strain (Interfauna Ibérica, S.A., Barcelona, Spain) 
weighing 180 to 200 g were used. They were housed individually in filter-top cages and screened for the presence of C. albicans by 
plating oral swabs on YEPD (yeast extract-peptonedextrose; Sigma Chemical Co., St. Louis, Mo.) agar (21). The cages were kept in 
a temperature-controlled (22 to 24°C) and humidity-controlled animal room, with an alternating light-dark cycle (lights on at 0600 
and lights off at 1800) and with food (diet A.03; Panlab, Barcelona, Spain) and sterile water ad libitum. 
Procedure. After verifying that the rats were free of C. albicans, we randomly divided them into three experimental groups of 
four animals each according to the treatment they were to be submitted to: either no treatment (i.e., no placebo or amphetamine) 
(control), placebo, or amphetamine. Treatment with drugs started 7 days before C. albicans inoculation and lasted until the end of 
the experiments, day 15 postinoculation. 
Surgical hyposalivation. As in humans, xerostomia in rats facilitates the establishment and persistence of C. albicans infection 
in the mouth; therefore, it constitutes a suitable animal model for the study of oral candidiasis (17). Sialoadenectomy in rats causes 
intense xerostomia, but the minor salivary glands, the main producers of mucin, an important barrier for mucosal permeability and a 
major source of immunoglobulin A, were preserved. In our experiment, xerostomia was surgically provoked in all rats 1 month 
before treatment with drugs was initiated. The rats were anesthetized with 44 mg of ketamine (Ketolar; Parke-Davis, Barcelona, 
Spain) per kg of body weight and 1 mg of diazepam (Valium; Roche, Madrid, Spain) per kg (31). The parotid salivary ducts of the 
animals were ligated, and the submandibular and sublingual salivary glands were surgically removed according to procedures 
previously described (6, 20, 21). 
Source and culture of C. albicans. The C. albicans organisms used to inoculate the rats were obtained from a patient with 
erythematous oral candidiasis. The Candida strain was grown on YEPD agar plates at room temperature (27). The isolated 
organisms were identified as C. albicans by a germ tube test and chlamydospore production as described by Schaar et al. (28). 
Inoculation of C. albicans. The C. albicans isolates were prepared for inoculation by suspending colonies in sterile buffered 
saline, washing and centrifuging them twice in the saline, and then resuspending them in the saline. The concentration of organisms 
was adjusted to 3 3 108/ml (1) by hemocytometer count. The tongues of the animals were swabbed on two successive days with a 
cottontipped applicator (21) saturated with 0.1 ml of fresh inoculum. 
Quantification of C. albicans cells. Establishment of C. albicans infection was evaluated by swabbing the inoculated oral 
cavity with a sterile cotton applicator, followed by plating on YEPD agar (17). Samples were collected 2 days after inoculation and 
at the end of the experiment. The cotton applicator was immediately immersed in 0.99 ml of sterile isotonic saline to obtain a 
dilution of 1022, and it was agitated for 2 min. This dilution was considered to be 1022. Dilutions up to 1025 (0.1 ml) were cultured 
in duplicate in Sabouraud’s dextrose agar at 37°C for 48 h. Candida colonies were counted in plates exhibiting between 30 and 300 
colonies. Plates with fewer than 30 colonies in the 1022 dilution were considered to have 101 cells (17). 
Clinical lesions. At the end of the experiment, the animals were killed by asphyxiation in a CO2 atmosphere and were then 
decapitated. The dorsal tongue was photographed in situ at a magnification of 310 (1). Clinical lesions were measured with a digital 
imaging system (Técnicas Médicas MAB, Barcelona, Spain) and were expressed as the percentage of the surface area of the tongue 
(percent area) that was covered with the lesions. 
Tissue handling. The tongues from the rats were hemisected in the sagittal plane, with half of the lesion immersed in 10% 
buffered formalin for routine processing and the other half placed in 2.5% glutaraldehyde with 0.1 M Sorensen’s phosphate buffer at 
4°C (1). 
Light microscopy. Both hematoxylin and eosin stain and periodic acid-Schiff stain were used. C. albicans infection was 
assessed by evidence of lesions and by hyphal colonization on the dorsal tongue (1, 24) with a digital imaging system. Tissue injury 
was determined by the quantification of the number and type (normal, atrophic, and hypertrophic) of papillae per microscopic field 
(magnification, 346). A semiquantitative scale was devised to assess the degree of colonization of the epithelium by fungal hyphae. 
In this scale, the absence of colonization was given a score of 0, while maximal colonization, where in excess of 50 hyphae could be 
seen in each high-power field (magnification, 3400), was assigned a score of 4 (24). The scores given were 1 for 1 to 5 hyphae, 2 for 
6 to 15 hyphae, and 3 for 16 to 50 hyphae. The specimens were examined by one of us, who was blinded as to the source. 
Scanning electron microscopy. Following fixation for 24 h, the tissue was rinsed three times in buffer and postfixed in 1% 
phosphate-buffered osmium tetroxide (pH 7.4) for 1 h. After two buffer rinses, the specimens were dehydrated in ascending 
concentrations of ethanol, followed by critical point dehydration in a Denton DCP-1 critical point drying apparatus with liquid CO2. 
The tissue samples were affixed on aluminum stubs with silver conductive paint and were sputter-coated with gold-palladium by 
using a Hummer VI sputter-coating apparatus (Anatech Electronics). Specimens were viewed with a Zeiss 910 electron microscope 
(Zeiss, Oberkochen, Germany) operated at 20 kV (2). 
Treatment with drugs. Racemic amphetamine sulfate (Sigma Chemical Co.) was subcutaneously injected at a dose of 0.4 
mg/kg in a volume of 1 ml of 0.9% saline solution per kg. The basis for employing this low dose of amphetamine is based on 
previous dose-response assays that proved to affect the immune system (12, 13, 23). Rats in the placebo group were subcutaneously 
injected with 1 ml of 0.9% saline solution per kg. Drugs were administered daily at 0930. 
Statistical analysis. Statistical analysis of the quantitation of C. albicans cells in oral tissue was performed by using the one-
way analysis of variance, followed by Bonferroni’s t test. Percent areas of clinical lesions were analyzed by Student’s t test (17). 
The Wilcoxon signed-rank sum test for paired comparisons and the Kruskal-Wallis test for multiple comparisons were used to 
determine the degree of colonization of the epithelium by fungal hyphae (24). Differences were considered significant at a P value 
of < 0.05. 
RESULTS 
C. albicans counts 2 and 15 days after inoculation were greater in amphetamine-treated rats than they 
were in control and placebo-treated rats (Table 1). The mean percent areas of clinical legions 6 standard 
deviations in the dorsal tongue were also greater in amphetamine-treated rats (68.308 ± 5.8) than they 
were in control (4.160 ± 0.4) and placebo-treated (4.424 ± 0.8) rats. A decrease in the total number of 
papillae and an increase in the percentage of abnormal (atrophic and hypertrophic) papillae (Fig. 1) were 
observed in rats injected with amphetamine compared with the total numbers and percentages observed in 
the control and placebo-treated rats (differences, P<, 0.01). Significant differences (P < 0.05) between 
untreated controls and placebo-injected rats in the latter parameter were observed.  
TABLE 1. C. albicans counts from the tongues of rats 
Day postinoculation 
Mean Candida count (104 CFU/ml) ± SD in rats receivinga: 
No treatmen (control) Placebo Amphetamine 
    
2 60.75 ± 2.04 60.39 ± 2.75 65.11 ± 3.16*† 
15 4.53 ± 1.04 4.72 ± 1.75 6.33 ± 0.08*† 
    
a Establishment of C. albicans infection was evaluated by swabbing the inoculated oral cavity with a sterile cotton applicator, 
followed by plating on YEPD agar. *, differences between control and amphetamine-treated rats were considered significant at a P 
value of , < 0.05; †, differences between placebo- and amphetamine-treated rats were considered significant at a P value of < 0.05. 
On the semiquantitative scale of colonization of the epithelium by fungal hyphae (Table 2), both 
placebo- and amphetamine-treated rats scored higher than untreated controls (differences, P < 0.05). 
Nevertheless, the scores were higher in amphetamine-injected rats than they were in placebo-injected rats 
(differences, P < 0.01). 
Clinically evident lesions and inflammatory changes of the underlying connective tissue were 
observed 15 days after C. albicans inoculation. The latter were found in all experimental groups, but they 
were most evident in the amphetaminetreated rats. Animals showed macroscopic focal patchy atrophy of 
the dorsal tongue papillae. Light microscopy showed localized dense zones of hyphal penetration of the 
keratin layer in the giant conical papillae and filiform papillae of the dorsal tongue. Microabscesses in the 
keratin and the superficial spinous layers were observed in association with hyphal invasion. The 
underlying connective tissue showed a mild chronic inflammatory cell infiltrate. Those papillae which 
supported the candidal growth appeared shorter and blunter than the surrounding uninfected papillae. 
Scanning electron microscopy of the dorsal tongues from rats injected with amphetamine and infected 
with C. albicans showed a higher loss of papillae in the giant conical and filiform areas of the specimens 
than the control and placebo treated rats showed, together with an increase in the size of the flat central 
portion of the lesion in comparison with the control and placebo-treated rats. 
DISCUSSION 
Our results show that amphetamine exacerbates C. albicans infection of the tongues of rats. 
Significant increases in Candida counts, the percent area of clinical lesions, the percentage of abnormal 
papillae, and the colonization of the epithelium by fungal hyphae were found in amphetamine-treated rats 
compared with those found in rats injected with the placebo. The last two parameters increased in the 
placebo-treated rats compared with the parameters of the untreated control rats, possibly as a consequence 
of stress-induced effects of animal handling on the immune system (23). In previous investigations, we 
had observed that amphetamine did not statistically affect these two parameters in noninoculated animals. 
C. albicans is an opportunistic human pathogen which preferentially causes invasive and disseminated 
infections in patients with defective phagocytic defenses as well as serious mucocutaneous infection in 
patients with deficiencies in T-cell function (19). Clinical and experimental observations indicate that the 
opportunistic proclivities of this fungus vary considerably, depending on the nature of the immunological 
defect of the victim. Patients with qualitative or quantitative defects of phagocytes are mainly prone to the 
invasive form of this mycosis (8, 9, 30). In contrast, defective T-cell-mediated immunity candidiasis 
limited to mucocutaneous surfaces (10, 15, 18). In this regard, Krause and Schaffner (19) demonstrated 
that cyclosporine, a relatively selective suppressor of T-cell-mediated immunity and NK cell activity, 
promoted the formation of thrushlike lesions in artificial pneumatized cyst surfaces and impeded the 
elimination of C. albicans from such lesions, but it had no effect on systemic candidiasis induced by 
intravenous inoculation. 
These results are in agreement with previous reports on the adverse effects of amphetamine on the 
immune systems of rodents. Both defective T-cell-mediated immunity (11, 12) and qualitative or 
quantitative defects of phagocytes (12) have been found in mice repeatedly injected with amphetamine. 
Moreover, amphetamine was found to decrease the resistance to and the development and passive transfer 
of immunity to Listeria monocytogenes (11) in C57BL/6 mice and to increase the lethality and 
pathogenicity of influenza A virus (PR8/34) in CD-1 mice (22). 
The mechanism for the action of amphetamine might be either direct (at a target cell) or indirect 
(affecting neuroendocrine pathways). House et al. (16) found that natural and synthetic amphetamines 
exhibit direct immunomodulatory activities following in vitro exposure. Amphetamine was found to 
suppress interleukin 2 production by T lymphocytes, B-lymphocyte proliferation, and NK cell function 
under in vitro conditions.  
FIG. 1. Total number of papillae and percentages of normal and abnormal (atrophic and hypertrophic) papillae on the tongues of 
rats. The results are the means ± standard deviations of four animals. Values were analyzed by Bonferroni’s t test.*, differences 
between control and amphetamine-treated rats were considered significant at a P value of <0.01; ♦ , differences between placebo- 
and amphetamine-treated rats were considered significant at a P value of < 0.01; ♣ , differences between control and placebo- and 
amphetamine-treated rats were considered significant at a P value of <0.05. 
The effects of amphetamine can also be secondary to a mediator involved in expressing the drug’s 
effect. Amphetamine has been shown to have numerous effects on neuronal and endocrine systems. 
Molecular products of cells of the nervous and immune systems provide a means of communication 
between the two systems (5). Many of the effects of amphetamine involve the drug modulation of the 
adrenergic system and mimic stress-like states (3, 7, 14, 29). Cellular immune activity is partially 
regulated by the adrenergic nervous system (4). 
A second point to be considered concerns the neuroendocrinological effects of amphetamine. The 
stimulatory effect of amphetamine on adrenocorticotropic hormone (ACTH) and adrenocorticoids should 
be involved (16, 25). Firstly, ACTH from the pituitary gland, and even ir-ACTH of lymphocyte origin, 
has a direct inhibitory effect on the functional capacities of immune cells. Secondly, the rise in plasma 
corticosterone concentrations, via ACTH secretion enhancement, suppresses various aspects of immune 
function (26). Previous investigations have shown a stimulatory effect of chronic amphetamine on ACTH 
secretion that was proportional to the decrease in the functional activities of spleen cells and the activity 
of phagocytosis (12). Nevertheless, it was observed that adrenalectomized mice showed less but 
statistically significant immunosuppression in response to amphetamine administration. 
This led members of our group to believe that other neuropeptides and neurotransmitters (i.e., 
prolactin, endorphins, thyrotropin, and dopamine) might be involved in the immunological response to 
amphetamine. However, the large number of interactions at the molecular, cellular, and functional levels 
between the nervous and immune systems that characterize the operational compositions and expressions 
of the neuroimmune network make the isolation of the pathways in which amphetamine may be involved 
in the regulation of the immune responses complex. Therefore, many questions still need to be addressed 
in order to understand more fully the immunosuppressive characteristics of amphetamine. 
In conclusion, our data at present show that amphetamine, through known and unknown 
neuroendocrine pathways, should injure the elements of the immunological apparatus, which in turn may 
leave the subject vulnerable to the action of C. albicans. 
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